ArticleArtificial intelligence in medicine
An MLP-based feature subset selection for HIV-1 protease cleavage site analysis.
Article in Artificial intelligence in medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 38 citations in OpenAlex.
- Surgical Methods and Social Factors Are Associated With Long-Term Survival in Follicular Thyroid Carcinoma: Construction and Validation of a Prognostic Model Based on Machine Learning Algorithms.Frontiers in oncology · 2022Article
- RGIFE: a ranked guided iterative feature elimination heuristic for the identification of biomarkers.BMC bioinformatics · 2017Article
- The importance of physicochemical characteristics and nonlinear classifiers in determining HIV-1 protease specificity.Bioengineered · 2016Article
- A consistency-based feature selection method allied with linear SVMs for HIV-1 protease cleavage site prediction.PloS one · 2013Article
Corrections and comments
- Commented on by
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveIn recent years, several machine learning approaches have been applied to modeling the specificity of the human immunodeficiency virus type 1 (HIV-1) protease cleavage domain. However, the high dimensional domain dataset contains a small number of samples, which could misguide classification modeling and its interpretation. Appropriate feature selection can alleviate the problem by eliminating irrelevant and redundant features, and thus improve prediction performance.
methodsWe introduce a new feature subset selection method, FS-MLP, that selects relevant features using multi-layered perceptron (MLP) learning. The method includes MLP learning with a training dataset and then feature subset selection using decompositional approach to analyze the trained MLP. Our method is able to select a subset of relevant features in high dimensional, multi-variate and non-linear domains.
resultsUsing five artificial datasets that represent four data types, we verified the FS-MLP performance with seven other feature selection methods. Experimental results showed that the FS-MLP is superior at high dimensional, multi-variate and non-linear domains. In experiments with HIV-1 protease cleavage dataset, the FS-MLP selected a set of 14 highly relevant features among 160 original features. On a validation set of 131 test instances, classifiers that used the 14 features showed about 95% accuracy which outperformed other seven methods in terms of accuracy and the number of features.
conclusionsOur experimental results indicate that the FS-MLP is effective in analyzing multi-variate, non-linear and high dimensional datasets such as HIV-1 protease cleavage dataset. The 14 relevant features which were selected by the FS-MLP provide us with useful insights into the HIV-1 cleavage site domain as well. The FS-MLP is a useful method for computational sequence analysis in general.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.